Covid Vaccine Blood Clotting
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Denmark Bars Johnson & Johnson Vaccine From Covid Vaccination Programme
Denmark said Monday it will bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following a similar move against the AstraZeneca jab.
-
Canadian PM Justin Trudeau Gets First Dose Of AstraZeneca Covid Vaccine
Prime Minister Justin Trudeau received a first dose of the AstraZeneca Covid vaccine on Friday, seeking to reassure Canadians it is safe despite very rare but serious blood clots in a handful of cases among millions vaccinated.
-
One Dead, Another Critical In US After J&J Covid Jab: Official
One US patient died from blood clotting complications after receiving the Johnson & Johnson Covid vaccine while another is in critical condition, a senior scientist for the Food and Drug Administration said Tuesday.
-
Ireland To Limit AstraZeneca Covid Shot To Over-60s
Ireland's vaccine taskforce on Monday recommended the AstraZeneca coronavirus jab be limited to those aged over 60, following European reviews of evidence linking the shot to rare blood clotting events.
-
No Causal Link Found Between J&J Vaccine, Blood Clots: US Drug Regulator
Top US health authorities said Friday they have not yet found a "causal" link between Johnson & Johnson's Covid shot and blood clots, as the EU drug regulator probed possible instances among those who have received the vaccine.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Denmark Bars Johnson & Johnson Vaccine From Covid Vaccination Programme
Denmark said Monday it will bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following a similar move against the AstraZeneca jab.
-
Canadian PM Justin Trudeau Gets First Dose Of AstraZeneca Covid Vaccine
Prime Minister Justin Trudeau received a first dose of the AstraZeneca Covid vaccine on Friday, seeking to reassure Canadians it is safe despite very rare but serious blood clots in a handful of cases among millions vaccinated.
-
One Dead, Another Critical In US After J&J Covid Jab: Official
One US patient died from blood clotting complications after receiving the Johnson & Johnson Covid vaccine while another is in critical condition, a senior scientist for the Food and Drug Administration said Tuesday.
-
Ireland To Limit AstraZeneca Covid Shot To Over-60s
Ireland's vaccine taskforce on Monday recommended the AstraZeneca coronavirus jab be limited to those aged over 60, following European reviews of evidence linking the shot to rare blood clotting events.
-
No Causal Link Found Between J&J Vaccine, Blood Clots: US Drug Regulator
Top US health authorities said Friday they have not yet found a "causal" link between Johnson & Johnson's Covid shot and blood clots, as the EU drug regulator probed possible instances among those who have received the vaccine.
